SB 321 would effectively eliminate an estimated 95% of Alabama’s hemp product market by classifying hemp-derived psychoactive cannabinoids, including Delta-8, Delta-9, and Delta-10 THC, as Schedule I controlled substances and repealing the existing 21+ regulated sales framework.

Introduced on 2/24/26, the bill would remove the current statutory exemption for THC found in hemp and instead limit the exemption to non-psychoactive cannabinoids only. Although existing law lists THC as a Schedule I substance while broadly exempting THC derived from hemp, SB 321 narrows that exemption and explicitly treats hemp-derived psychoactive cannabinoids as controlled substances, regardless of source.

In addition, the bill repeals the provisions that currently allow certain consumable hemp products containing psychoactive cannabinoids to be sold to individuals 21 and older subject to testing, labeling, and retail restrictions — replacing a regulated marketplace with prohibition.

Alabama Residents – Take Action: Contact your lawmakers and urge them to oppose SB 321.

SB1 (Oppose)

Alabama SB 1 would reclassify psychoactive hemp-derived cannabinoids (delta 8/9/10, etc.) as controlled substances, effectively banning intoxicating hemp, confine CBD-type consumables to pharmacies only beginning January 1, 2026 (with Board of Pharmacy oversight), and limit lawful consumables to products made from Alabama-grown hemp.

Alabama residents:
Take Action: Contact state lawmakers to oppose SB 1 and SB 321